DMCC Speciality Chemicals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved the results and several key corporate governance decisions during their meeting held on February 6, 2026.

Financial Performance Highlights

The company delivered strong revenue growth in Q3FY26 across both standalone and consolidated operations, though profitability faced some pressure compared to the previous year.

Standalone Results

For the nine months ended December 31, 2025, the company reported net sales of ₹40,387.49 lakhs compared to ₹30,604.67 lakhs in the corresponding period of the previous year, representing a growth of 31.97%. Net profit for the nine-month period stood at ₹1,966.78 lakhs versus ₹1,506.95 lakhs in the previous year, marking an increase of 30.51%.

Consolidated Performance

Key Board Decisions

The Board of Directors approved several significant corporate governance and operational matters during their meeting held from 1:00 p.m. to 3:05 p.m. IST on February 6, 2026.

Management Re-appointment

Shri Bimal Lalitsingh Goculdas brings over three decades of experience across India and USA, with expertise in production, technology, supply chain, marketing, and finance. He is a distinguished Chemical Engineer with postgraduate qualifications from the USA.

Corporate Governance Updates

The board approved several amendments to align the company's governance framework with current regulatory requirements:

• Remuneration Enhancement: Increase in remuneration for Shri Kuldeep Kumar Tiwari (DIN: 10633725), Executive Director (Operations), subject to member approval through postal ballot
• MOA Amendments: Changes to the object and liability clause of the Memorandum of Association to align with Companies Act, 2013
• AOA Adoption: New set of Articles of Association replacing the existing framework based on Companies Act, 1956
• Postal Ballot Authorization: Notice for seeking shareholder approval on governance matters

Operational Insights

The company's operations remain focused on manufacturing and sale of chemicals as a single business segment. Key operational metrics for Q3FY26 included:

The consolidated results include contributions from subsidiary DMCC (Europe) GMBH, which contributed revenue of ₹3.35 lakhs and net profit of ₹0.86 lakhs for the quarter.

Regulatory Compliance

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by statutory auditors Rahul Gautam Divan & Associates. The auditors expressed an unmodified review opinion on the results. The company has also recognized adjustments of ₹12.59 lakhs related to the new Labour Codes notified by the Government of India on November 21, 2025.

DMCC Specialty Chemicals has announced a key board appointment, naming Ms. Saloni Jhaveri as an independent director. The appointment marks a significant addition to the company's governance structure as it continues to strengthen its leadership team.

Board Appointment Details

The company has provided specific details regarding the new directorship appointment:

Strategic Governance Enhancement

The appointment of Ms. Saloni Jhaveri as an independent director represents the company's commitment to maintaining robust corporate governance practices. Independent directors play a crucial role in providing objective oversight and bringing diverse perspectives to board deliberations.

Future Implementation

With the appointment scheduled to take effect from January 10, 2026, DMCC Specialty Chemicals is planning ahead for its board composition. The five-year term provides stability and continuity for the company's governance framework, ensuring consistent independent oversight during this period.

This board appointment reflects the company's proactive approach to corporate governance and its focus on building a strong leadership foundation for future operations.